Trial · NCT04172441
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part 1-1: First Intervention (48 Hours) | STARTED | Dasiglucagon, Then Placebo | 7 | |
| Part 1-1: First Intervention (48 Hours) | STARTED | Placebo, Then Dasiglucagon | 5 | |
| Part 1-1: First Intervention (48 Hours) | COMPLETED | Dasiglucagon, Then Placebo | 7 | |
| Part 1-1: First Intervention (48 Hours) | COMPLETED | Placebo, Then Dasiglucagon | 5 | |
| Part 1-1: First Intervention (48 Hours) | NOT COMPLETED | Dasiglucagon, Then Placebo | 0 | |
| Part 1-1: First Intervention (48 Hours) | NOT COMPLETED | Placebo, Then Dasiglucagon | 0 | |
| Part 1-2: Second Intervention (48 Hours) | STARTED | Dasiglucagon, Then Placebo | 7 | |
| Part 1-2: Second Intervention (48 Hours) | STARTED | Placebo, Then Dasiglucagon | 5 | |
| Part 1-2: Second Intervention (48 Hours) | COMPLETED | Dasiglucagon, Then Placebo | 7 | |
| Part 1-2: Second Intervention (48 Hours) | COMPLETED | Placebo, Then Dasiglucagon | 5 | |
| Part 1-2: Second Intervention (48 Hours) | NOT COMPLETED | Dasiglucagon, Then Placebo | 0 | |
| Part 1-2: Second Intervention (48 Hours) | NOT COMPLETED | Placebo, Then Dasiglucagon | 0 | |
| Part 2: Open Label Dasiglucagon | STARTED | Dasiglucagon, Then Placebo | 7 | |
| Part 2: Open Label Dasiglucagon | STARTED | Placebo, Then Dasiglucagon | 5 | |
| Part 2: Open Label Dasiglucagon | Completed Treatment | Dasiglucagon, Then Placebo | 7 | |
| Part 2: Open Label Dasiglucagon | Completed Treatment | Placebo, Then Dasiglucagon | 4 | |
| Part 2: Open Label Dasiglucagon | COMPLETED | Dasiglucagon, Then Placebo | 7 | |
| Part 2: Open Label Dasiglucagon | COMPLETED | Placebo, Then Dasiglucagon | 5 | |
| Part 2: Open Label Dasiglucagon | NOT COMPLETED | Dasiglucagon, Then Placebo | 0 | |
| Part 2: Open Label Dasiglucagon | NOT COMPLETED | Placebo, Then Dasiglucagon | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04172441/flow